Back to results
US 8,263,776 B2Granted
Inhibitors of c-Met protein kinase
AssigneeVertex Pharmaceuticals Incorporated
InventorsDavid Lauffer, Pan Li
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula I, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.
Claims7
A compound having the formula:
- or a pharmaceutically acceptable salt thereof, wherein each R1 is, independently, hydrogen or fluoro.
Dependencies are inferred from the claim text.